Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study

Enoxaparin is indicated for thromboprophylaxis in non-orthopedic surgical patients at a fixed dose of 40 mg daily. According to the US Food and Drug Administration’s enoxaparin prescribing information, this dose exposes low-weight patients (males < 57 kg, females < 45 kg) to a higher risk of b...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Appl Thromb Hemost
Main Authors: Hakeam, Hakeam A., Al Duhailib, Zainab, Alsemari, Muhannad, Alwaibah, Reem M., Al Shannan, Madhawi F., Shalhoub, Munirah
格式: Artigo
語言:Inglês
出版: SAGE Publications 2020
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7427004/
https://ncbi.nlm.nih.gov/pubmed/32559127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029620931194
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍